Showing results (81-90 of 181) with videos related to
Sort By:
Pageof 19
Plos One|September 18, 2012
A p53-Pax2 pathway in kidney development: implications for nephrogenesisZubaida Saifudeen, Jiao Liu, Susana Dipp, et al.Conservation Biology : the Journal of the Society for Conservation Biology|February 10, 2021
Change in avian functional fingerprints of a Neotropical montane forest over 100 years as an indicator of ecosystem integrityCamila Gómez, Elkin A Tenorio, Carlos Daniel CadenaMolecular Phylogenetics and Evolution|February 6, 2007
Evolutionary differentiation in the Neotropical montane region: molecular phylogenetics and phylogeography of Buarremon brush-finches (Aves, Emberizidae)Carlos Daniel Cadena, John Klicka, Robert E RicklefsJournal of Clinical & Translational Endocrinology|October 26, 2017
The interdisciplinary team in type 2 diabetes management: Challenges and best practice solutions from real-world scenariosMargaret McGill, Lawrence Blonde, Juliana C N Chan, et al.Proceedings. Biological Sciences|May 20, 2025
Nest location and architecture as primary drivers of variation in UV reflectance in avian eggsMaria Elisa Mendiwelso, Carlos Daniel Cadena, David OcampoLancet (London, England)|May 27, 2015
Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority studyLawrence Blonde, Johan Jendle, Jorge Gross, et al.The Journal of Biological Chemistry|August 26, 2006
The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repressionDiederik Van Bodegom, Zubaida Saifudeen, Susana Dipp, et al.Endocrinology, Diabetes & Metabolism|July 12, 2019
Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysisDenis Raccah, Bruno Guerci, Mayank Ajmera, et al.Cardiovascular Diabetology|January 15, 2017
Differential effects of glucagon-like peptide-1 receptor agonists on heart rateMartin Lorenz, Francesca Lawson, David Owens, et al.Pharmacoeconomics|August 16, 2005
Real-world trials to answer real-world questionsNick Freemantle, Lawrence Blonde, Bjorn Bolinder, et al.Pageof 19